(Q51471902)
Statements
Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. (English)
1 reference
Robert S Rosenson
1 reference
David A Wolff
1 reference
Anna L Huskin
1 reference
Irene B Helenowski
1 reference
Alfred W Rademaker
1 reference
4 May 2007
1 reference
30
1 reference
8
1 reference
1945-1951
1 reference